Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expression-Reference-Cited by-同舟云学术

Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expression

Published:2014-02-10 Issue:5 Volume:29 Page:753-763
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Sneddon Deborah¹,Poulsen Sally-Ann¹

Affiliation:

1. Eskitis Institute for Drug Discovery, Griffith University Brisbane, QueenslandAustralia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/14756366.2013.848205

Reference70 articles.

1. Molecular Imaging and Contrast Agent Database (MICAD). About MICAD. Bethesda (MD): National Center for Biotechnology Information, NLM, NIH; 2004-2013. Available from: http://micad.nih.gov

2. Molecular Imaging and Contrast Agent Database (MICAD): Evolution and Progress

3. MICAD. MICAD Overview Powerpoint Presentation 2004–2013

4. Molecular imaging in cancer treatment

5. Leung K. 124I-Chimeric monoclonal antibody G250. Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD): National Center for Biotechnology Information, NLM, NIH; 2004-2013. [last updated: 20 May 2010]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK43528/

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX;Bioconjugate Chemistry;2024-05-15

2. Carbonic Anhydrase-IX Guided Albumin Nanoparticles for Hypoxia-mediated Triple-Negative Breast Cancer Cell Killing and Imaging of Patient-derived Tumor;Molecules;2020-05-19

3. A Biomimetic Drug Delivery System Targeting Tumor Hypoxia in Triple-Negative Breast Cancers;Applied Sciences;2020-02-05

A new strategy for accurate targeted diagnosis and treatment of cutaneous malignant melanoma: dual-mode phase-change lipid nanodroplets as ultrasound contrast agents

;International Journal of Nanomedicine;2019-09

5. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors;Expert Opinion on Investigational Drugs;2018-11-22